AIMIA DECLARES PREFERRED SHARE DIVIDENDS
TORONTO, Nov. 8, 2024 /CNW/ - Aimia Inc. (TSX: AIM) today announced that its Board of Directors has declared quarterly dividends on each series of its preferred shares:
- A quarterly dividend in the amount of $0.300125 per Cumulative Rate Reset Preferred Share, Series 1.
- A quarterly dividend in the amount of $0.485813 per Cumulative Rate Reset Preferred Share, Series 3.
- A quarterly dividend in the amount of $0.528183 per Floating Dividend Rate Preferred Share, Series 4. The Floating Quarterly Dividend Rate will be reset every quarter.
In each case, dividends are payable on December 31, 2024 to the holders of record at the close of business on December 17, 2024.
Dividends paid by Aimia to Canadian residents on its preferred shares are "eligible dividends" for the purpose of the Income Tax Act (Canada) and any similar applicable provincial legislation.
About Aimia
Aimia Inc. (TSX: AIM) is a diversified company focused on unlocking the growth potential of its two global businesses, Bozzetto, a sustainable specialty chemicals company, and Cortland International, a rope and netting solutions company. Headquartered in Toronto, Aimia's priorities include monetizing its non-core investments, enhancing the value of our core holdings, returning capital to its shareholders, and efficiently utilizing its loss carry-forwards to create shareholder value. For more information about Aimia, visit www.aimia.com.
SOURCE Aimia Inc.
Ausgewählte Hebelprodukte auf Hemispherx Biopharma
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Hemispherx Biopharma
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Hemispherx Biopharma Aktie News
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Hemispherx Biopharma Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Hemispherx Biopharma nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.